Genomic and Transcriptomic Analysis of Invasive Fungal Pathogens
侵袭性真菌病原体的基因组和转录组分析
基本信息
- 批准号:10597151
- 负责人:
- 金额:$ 79.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-15 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAnimal ModelAntifungal AgentsAntifungal TherapyBindingBiological AssayBiologyCRISPR/Cas technologyCandida aurisCellsChemotherapy-Oncologic ProcedureClinicalClustered Regularly Interspaced Short Palindromic RepeatsCommunicable DiseasesCommunitiesComplexDataData SetDevelopmentDisease OutcomeDrug resistanceElementsFamilyGene Expression RegulationGenesGenetic TranscriptionGenomeGenomic approachGenomicsGoalsGrowthImmune responseImmune systemImmunocompromised HostImmunosuppressive AgentsIndividualInfectionInvadedInvestigationKnowledgeMammalian CellMediatingMedicalMetabolic PathwayMicrobeMolecularMucoralesMucormycosisMycosesNatureOperative Surgical ProceduresOrgan TransplantationOrganismPathogenesisPatientsPharmaceutical PreparationsPhylogenetic AnalysisPrevalencePrevention strategyResistanceResourcesScedosporiumTechnologyTestingThe science of MycologyTherapeuticTissuesTranscriptUnited StatesUntranslated RNAVaccinesVirulentWorkclinically significantcombatcomparativecomparative genomicsdeep sequencingdesignexperimental studyfollow-upfungal geneticsfungusgene functiongenetic analysisgenetic elementgenome analysishigh riskhuman diseasein vivoinsightinterestmortalitymouse modelnew therapeutic targetnovelnovel strategiesnovel therapeutic interventionpathogenpathogenic funguspreventrapid growthresponsetherapeutic targettranscriptometranscriptome sequencingtranscriptomicstreatment strategywhole genome
项目摘要
SUMMARY/ABSTRACT
There has been a dramatic rise in the number of severe fungal infections due to a constant increase in the
number of individuals who are immunocompromised. Strong similarities in the basic eukaryotic metabolic
pathways between fungi and mammalian cells have hindered the development of antifungal agents because
many compounds that are effective at inhibiting fungal growth are also toxic to host cells. It is becoming clear
that novel antifungal agents alone are unlikely to significantly reduce the mortality rate of fungal infections
without the aid of new therapeutic approaches. Promising alternative approaches include combining current
antifungal treatments with agents that enhance the host immune system's ability to eliminate the microbe or
disrupt an interspecies molecular interaction that governs invasion. These approaches require a detailed
understanding of the complex interaction between host and pathogen. This proposal will focus on three
emerging fungal pathogens - Scedosporium spp, Candida auris and Mucorales fungi. Infections with these
three phylogenetically distinct pathogens frequently fail to respond to currently available antifungal therapy and
are therefore associated with extremely high mortality rates. Here we will combine dual-species RNA-seq,
comparative genome analysis, established animal models and fungal genetics to systematically and
comprehensively analyze the host-pathogen interactions for each class. Analyzing all three different types of
fungi using the same approach will enable us to define commonalities as well as key differences among the
organisms and the responses they elicit in the host. The proposed studies will provide a wealth of information
regarding gene function and regulation in both the fungus and the host and will likely lead to the identification
of novel therapeutic targets to treat this increasingly serious cause of human disease.
摘要/摘要
由于真菌感染的持续增加,严重真菌感染的数量急剧增加。
免疫功能低下的个体数量。真核生物的基本代谢有很强的相似性
真菌和哺乳动物细胞之间的通路阻碍了抗真菌药物的开发,因为
许多能有效抑制真菌生长的化合物对宿主细胞也有毒。情况逐渐明朗
单独使用新型抗真菌药物不太可能显着降低真菌感染的死亡率
无需新的治疗方法的帮助。有希望的替代方法包括结合当前的
使用增强宿主免疫系统消除微生物能力的药物进行抗真菌治疗,或
破坏控制入侵的种间分子相互作用。这些方法需要详细的
了解宿主和病原体之间复杂的相互作用。该提案将重点关注三个方面
新出现的真菌病原体 - Scedosporium spp、耳念珠菌和毛霉目真菌。感染这些
三种系统发育上不同的病原体经常无法对当前可用的抗真菌治疗做出反应,并且
因此与极高的死亡率相关。这里我们将结合双物种RNA-seq,
比较基因组分析、建立动物模型和真菌遗传学,以系统地和
全面分析每个类别的宿主-病原体相互作用。分析所有三种不同类型
使用相同的方法对真菌进行研究将使我们能够定义真菌之间的共同点以及关键差异
生物体及其在宿主体内引起的反应。拟议的研究将提供丰富的信息
关于真菌和宿主的基因功能和调控,可能会导致鉴定
寻找新的治疗靶点来治疗这种日益严重的人类疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vincent Michael Bruno其他文献
Vincent Michael Bruno的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vincent Michael Bruno', 18)}}的其他基金
Therapeutic targeting of growth factor receptors to treat Mucormycosis
生长因子受体的治疗靶向治疗毛霉菌病
- 批准号:
10409703 - 财政年份:2019
- 资助金额:
$ 79.08万 - 项目类别:
Therapeutic targeting of growth factor receptors to treat Mucormycosis
生长因子受体的治疗靶向治疗毛霉菌病
- 批准号:
10163795 - 财政年份:2019
- 资助金额:
$ 79.08万 - 项目类别:
Therapeutic targeting of growth factor receptors to treat Mucormycosis
生长因子受体的治疗靶向治疗毛霉菌病
- 批准号:
10630197 - 财政年份:2019
- 资助金额:
$ 79.08万 - 项目类别:
Therapeutic targeting of growth factor receptors to treat Mucormycosis
生长因子受体的治疗靶向治疗毛霉菌病
- 批准号:
9814832 - 财政年份:2019
- 资助金额:
$ 79.08万 - 项目类别:
Genomic and Transcriptomic Analysis of Invasive Fungal Pathogens
侵袭性真菌病原体的基因组和转录组分析
- 批准号:
10132960 - 财政年份:2014
- 资助金额:
$ 79.08万 - 项目类别:
Genomic and Transcriptomic Analysis of Invasive Fungal Pathogens
侵袭性真菌病原体的基因组和转录组分析
- 批准号:
10375510 - 财政年份:2014
- 资助金额:
$ 79.08万 - 项目类别:
Genomic and Transcriptomic Analysis of Invasive Fungal Pathogens
侵袭性真菌病原体的基因组和转录组分析
- 批准号:
9901444 - 财政年份:
- 资助金额:
$ 79.08万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
利用肝癌动物模型开展化学可控的在体基因编辑体系的研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Antifungal discovery from previously uncultivated bacteria
从以前未培养的细菌中发现抗真菌药物
- 批准号:
10693593 - 财政年份:2023
- 资助金额:
$ 79.08万 - 项目类别:
Antifungals targeting pantothenate phosphorylation
靶向泛酸磷酸化的抗真菌药
- 批准号:
10696567 - 财政年份:2023
- 资助金额:
$ 79.08万 - 项目类别:
Targeted pan-antibacterial liposomes to control pathogenic mycobacteria
靶向泛抗菌脂质体控制致病性分枝杆菌
- 批准号:
10569282 - 财政年份:2023
- 资助金额:
$ 79.08万 - 项目类别:
Host Immunogenetics and Fungal Virulence Mechanisms in Coccidioidomycosis
球孢子菌病的宿主免疫遗传学和真菌毒力机制
- 批准号:
10356724 - 财政年份:2022
- 资助金额:
$ 79.08万 - 项目类别:
Validation of a novel rodent Candida-associated denture stomatitis model for studying pathogenesis and therapeutic management
验证一种新型啮齿动物念珠菌相关假牙口腔炎模型,用于研究发病机制和治疗管理
- 批准号:
10486400 - 财政年份:2022
- 资助金额:
$ 79.08万 - 项目类别: